Relationship between p21 Expression and Mutation of the p53 Tumor Suppressor Gene in Normal and Malignant Ovarian Epithelial Cells

Clinical Cancer Research

Volumn 2, Issue 9, 1996, Pages 1571-1575

  Elbendary, Alaa A ^a   Cirisano, Frank D ^a   Evans Jr , Anthony C ^a   Davis, Penelope L ^b   Iglehart, J Dirk ^b   Marks, Jeffrey R ^b   Berchuck, Andrew ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; MESSENGER RNA;

ARTICLE; CELL CULTURE; CYTOLOGY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MUTATION; NORTHERN BLOTTING; OVARY; PATHOLOGY; TUMOR SUPPRESSOR GENE;

BLOTTING, NORTHERN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; MUTATION; OVARY; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0030222999     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugen-Strano, A., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P , Ward, J., Tonin, P., Narod, S., Bristow, P. K., Norris, F. H., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barrett, J. C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb, A., and Skolnick, M. H. A strong candidate for the breast ovarian cancer susceptibility gene BRCA1. Science (Washington DC), 266: 66-71, 1994.
2. Berchuck, A., Elbendary, A., Havrilesky, L., Rodriguez, G. C., and Bast, R. C., Jr. Pathogenesis of ovarian cancers. J. Soc. Gynecol. Invest., 1: 181-190, 1994.
3. Berchuck, A., Kohler, M. F., Marks, J. R., Wiseman, R., Boyd, J., and Bast, R. C., Jr. The p53 tumor suppressor gene frequently is altered in gynecologic cancers. Am. J. Obstet. Gynecol., 170: 246-252, 1994.
4. Kohler, M F., Marks, J. R., Wiseman, R. W , Jacobs, I. J., Davidoff, A M., Clarke-Pearson, D. L., Soper, J. T., Bast, R. C., and Berchuck, A Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer. J. Natl. Cancer Inst., 85: 1513-1519, 1993.
5. Marks, J R., Davidoff, A. M., Kerns, B., Humphrey, P. A., Pence, J., Dodge, R., Clarke-Pearson, D L., Iglehart, J. D., Bast, R. C., Jr , and Berchuck, A. Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res , 51: 2979-2984, 1991.
6. Kohler, M. F., Kerns, B. J., Humphrey, P. A., Marks, J. R., Bast, R. C., and Berchuck, A Mutation and Overexpression of p53 in early-stage epithelial ovarian cancer. Obstet. Gynecol., 81: 643-650, 1993.
7. Baker, S. J., Markowitz, S., Fearon, E. R , Willson, J. K., and Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (Washington DC), 249: 912-915, 1990.
8. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of the p53 protein in the cellular response to DNA damage. Cancer Res., 57: 6304-6311, 1991.
9. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl. Acad. Sci. USA, 89: 7491-7495, 1992.
10. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
11. Harper, J. W., Adami, G. R., Wei, N , Keyomarsi, K., and Elledge, S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
12. Raycroft, L., Schmidt, J. R., Yoas, K., Hao, M. M., and Lozano, G. Analysis of p53 mutants for transcriptional activity. Mol. Cell. Biol., 11: 6067-6074, 1991.
13. Berchuck, A., Rodnguez, G. C., Olt, G J., Boente, M. P., Whitaker, R. S., Arrick, B., Clarke-Pearson, D. L., and Bast, R. C., Jr. Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-β Am. J Obstet Gynecol., 166: 676-684, 1992.
14. Rodriguez, G. C., Berchuck, A., Whitaker, R. S., Schlossman, D., Clarke-Pearson, D. L., and Bast, R. C., Jr. Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. II. Relationship between receptor expression and response to epidermal growth factor. Am. J. Obstet. Gynecol., 164: 745-750, 1991.
15. Kruk, P. A., Maines-Bandiera, S. L., and Auersperg, N. A simplified method to culture human ovarian surface epithelium. Lab. Invest., 63: 132-136, 1990.
16. Chomczynski, P. and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
17. Li, S. L., Kim, M. S., Cherrick, H. M., and Park, N. H. Low p53 level in immortal, non-tumorigenic oral keratinocytes harboring HPV-16 DNA. Eur. J. Cancer B. Oral Oncol., 28B: 129-134, 1992.
18. Sherr, C. J. G1 phase progression: cycling on cue. Cell, 79: 551-555, 1994.
19. Zhang, H., Xiong, Y., and Beach, D. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol. Biol. Cell, 4: 897-906, 1993.
20. Xiong, Y., Zhang, H., and Beach, D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell, 71: 505-514, 1992.
21. Xiong, Y., Zhang, H., and Beach, D. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev., 7: 1572-1583, 1993.
22. Chen, X., Bargonetti, J., and Prives, C. p53, through p21 (WAF1/ CIP1), induces cyclin D1 synthesis. Cancer Res., 55: 4257-4263, 1995.
23. 1 arrest is selectively mediated by the p53-WAF1/Cip1 pathway in human thyroid cells. Cancer Res. 55: 2075-2080, 1995.
24. 1 arrest and apoptosis. Cancer Res., 54: 1169-1174, 1994.
25. Shiohara, M., El-Deiry, W. S., Wada, M., Nakamaki, T., Takeuchi, S , Yang, R., Chen, D. L., Vogelstein, B., and Koeffler, H. P. Absence of WAF1 mutations in a variety of human malignancies. Blood, 84: 3781-3784, 1994.
26. Mousses, S., Ozcelik, H., Lee, P. D., Malkin, D., Bull, S. B., and Andrulis, I. L. Two variants of the CIP1/WAF1 gene occur together and are associated with human cancer. Hum. Mol. Genet., 4: 1089-1092, 1995.
27. Li, Y. J., Laurent-Puig, P., Salmon, R. J., Thomas, G., and Hamelin, R. Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer. Oncogene, 10: 599-601, 1995.
28. Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E., and Givol, D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res., 54: 3391-3395, 1994.
29. Li, C. Y., Suardet, L., and Little, J. B. Potential role of WAF1/ Cip1/p21 as a mediator of TGF-β cytoinhibitory effect. J. Biol. Chem., 270: 4971-4974, 1995.
30. Gudas, J., Nguyen, H., Li, T., Hill, D., and Cowan, K. H. Effects of cell cycle, wild-type p53 and DNA damage on p21CIP1/Waf1 expression in human breast epithelial cells. Oncogene, 11: 253-261, 1995.
31. Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., and Jacks, T. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev., 9: 935-944, 1995.
32. Cip1/Waf1 proteins following γ-irradiation of human lymphoma cells. Cancer Res., 55: 2387-2393, 1995.
33. Akashi, M., Hachiya, M., Osawa, Y., Spirin, K., Suzuki, G., and Koeffler, H. P. Irradiation induces WAF1 expression through a p53-independent pathway in KG-1 cells. J. Biol. Chem., 270: 19181-19187, 1995.
34. Hurteau, J., Rodriguez, G. C., Whitaker, R. S., Shah, S., Mills, G., Bast, R. C., and Berchuck, A. Transforming growth factor-β inhibits proliferation of human ovarian cancer cells obtained from ascites. Cancer (Phila.), 74: 93-99, 1994.
35. Elbendary, A., Berchuck, A., Davis, P., Havrilesky, L., Bast, R. C., Jr., Iglehart, J. D., and Marks, J. R. Transforming growth factor β1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth & Differ., 5, 1301-1307, 1994.
36. Zhang, W., Grasso, L., McClain, C. D., Gambel, A. M., Cha, Y., Travali, S., Deisseroth, A. B., and Mercer, W. E. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res., 55: 668-674, 1995.
37. Johnson, M., Dimitrov, D., Vojta, P. J., Barrett, J. C., Noda, A., Pereira-Smith, O. M., and Smith, J. R. Evidence for a p53-independent pathway for upregulation of SDI1/CIP1/WAF1/p21 RNA in human cells. Mol. Carcinog., 11: 59-64, 1994.
38. Yamato, K., Yamamoto, M., Hirano, Y., and Tsuchida, N. A human temperature-sensitive p53 mutant p53Val-138: modulation of the cell cycle, viability and expression of p53-responsive genes. Oncogene, 11: 1-6, 1995.
39. Sherr, C. J. Mammalian G1 cyclins. Cell, 73: 1059-1065, 1993.
40. Zhang, H., Hannon, G. J., and Beach, D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev., 8: 1750-1758, 1994.